Predictors for Permanent Discontinuation of Systemic Immunosuppression in Severely Affected Chronic Graft-Versus-Host Disease Patients
Open Access
- 1 November 2017
- journal article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 23 (11) , 1980-1988
Abstract
No abstract availableKeywords
Funding Information
- Intramural Research Program of the National Cancer Institute
- Center for Cancer Research
- NIH
This publication has 33 references indexed in Scilit:
- Progressive Improvement in Cutaneous and Extracutaneous Chronic Graft-versus-Host Disease after a 24-Week Course of Extracorporeal Photopheresis—Results of a Crossover Randomized StudyTransplantation and Cellular Therapy, 2011
- Clinical laboratory markers of inflammation as determinants of chronic graft-versus-host disease activity and NIH global severityLeukemia, 2011
- Treatment of chronic graft-versus-host disease: Past, present and futureThe Korean Journal of Hematology, 2011
- Tacrolimus/Methotrexate versus Cyclosporine/Methotrexate as Graft-versus-Host Disease Prophylaxis in Patients with Severe Aplastic Anemia Who Received Bone Marrow Transplantation from Unrelated Donors: Results of Matched Pair AnalysisTransplantation and Cellular Therapy, 2009
- Determinants of functional performance in long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD)Bone Marrow Transplantation, 2009
- Prognostic Factors of Chronic Graft-versus-Host Disease Following Allogeneic Peripheral Blood Stem Cell Transplantation: The National Institutes Health Scale Plus the Type of Onset Can Predict Survival Rates and the Duration of Immunosuppressive TherapyTransplantation and Cellular Therapy, 2008
- Measuring Therapeutic Response in Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group ReportTransplantation and Cellular Therapy, 2006
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group ReportTransplantation and Cellular Therapy, 2005
- Duration of immunosuppressive treatment for chronic graft-versus-host diseaseBlood, 2004
- Sclerodermatous chronic graft-versus-host diseaseJournal of the American Academy of Dermatology, 1992